NLRP 11 disrupts MAVS signalosome to inhibit type I interferon signaling and virus‐induced apoptosis

  • Qin Y
  • Su Z
  • Wu Y
  • et al.
29Citations
Citations of this article
36Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

MAVS signalosome plays an important role in RIG-I-like receptor (RLR)-induced antiviral signaling. Upon the recognition of viral RNAs, RLRs activate MAVS, which further recruits TRAF6 and other signaling proteins to initiate type I interferon (IFN) activation. MAVS signalosome also regulates virus-induced apoptosis to limit viral replication. However, the mechanisms that control the activity of MAVS signalosome are still poorly defined. Here, we report NLRP11, a Nod-like receptor, is induced by type I IFN and translocates to mitochondria to interact with MAVS upon viral infection. Using MAVS as a platform, NLRP11 degrades TRAF6 to attenuate the production of type I IFNs as well as virus-induced apoptosis. Our findings reveal the regulatory role of NLRP11 in antiviral immunity by disrupting MAVS signalosome.

Cite

CITATION STYLE

APA

Qin, Y., Su, Z., Wu, Y., Wu, C., Jin, S., Xie, W., … Cui, J. (2017). NLRP 11 disrupts MAVS signalosome to inhibit type I interferon signaling and virus‐induced apoptosis. EMBO Reports, 18(12), 2160–2171. https://doi.org/10.15252/embr.201744480

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free